CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals. (Q47572384)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Christopher J. Davies

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Leo M Njongmeta

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jocelyn Bray

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

William C Davis

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Chris J Howard

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Guy H Palmer

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Wendy C Brown

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Waithaka Mwangi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

10 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1624-1635

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Prospects for control of emerging infectious diseases with plasmid DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Optimization and delivery of plasmid DNA for vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Targeting with bovine CD154 enhances humoral immune responses induced by a DNA vaccine in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbre

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

DNA vaccine construct incorporating intercellular trafficking and intracellular targeting motifs effectively primes and induces memory B- and T-cell responses in outbred animals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Enhancement of immunogenicity of a therapeutic cervical cancer DNA-based vaccine by co-application of sequence-optimized genetic adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Vaccination of turkeys against Chlamydophila psittaci through optimised DNA formulation and administration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

CD4+ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

DNA vaccination: transfection and activation of dendritic cells as key events for immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

A monoclonal antibody specific for mouse dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2. results from a phase Ib clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Granulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: effects on papilloma formation and regression in the cottontail rabbit papillomavirus--rabbit model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Immunomodulatory effect of swine CCL20 chemokine in DNA vaccination against CSFV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Effect of plasmid DNA encoding the porcine granulocyte-macrophage colony-stimulating factor on antigen-presenting cells in pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

A versatile bifunctional dendritic cell targeting vaccine vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Single chain antibody fragments for the selective targeting of antigens to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti–human DEC205 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Molecular basis for surface antigen size polymorphisms and conservation of a neutralization-sensitive epitope in Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Molecular basis for vaccine development against anaplasmosis and babesiosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Characterization of a neutralization-sensitive epitope on the Am 105 surface protein of Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

DEC-205 expression on migrating dendritic cells in afferent lymph

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Current applications of COS cell based transient expression systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Recombinant soluble trimeric CD40 ligand is biologically active

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Cloning of two members of the TNF-superfamily in cattle: CD40 ligand and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Characterization of a phenotypically unique population of CD13+ dendritic cells resident in the spleen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Identification of fetal liver tyrosine kinase 3 (flt3) ligand domain required for receptor binding and function using naturally occurring ligand isoforms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Absorbable microparticulate cation exchanger for immunotherapeutic delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Improved immunogenicity of a self tumor antigen by covalent linkage to CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Linkage of CD40L to a self-tumor antigen enhances the antitumor immune responses of dendritic cell-based treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Immunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Synergistic antibody induction by antigen-CD40 ligand fusion protein as improved immunogen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Rapid deletion of antigen-specific CD4+ T cells following infection represents a strategy of immune evasion and persistence for Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Characterization of lymphocyte subpopulations and major histocompatibility complex haplotypes of mastitis-resistant and susceptible cows.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

Characterization of an immunoprotective protein complex of Anaplasma marginale by cloning and expression of the gene coding for polypeptide Am105L.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.110

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.12.110

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22240344%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47572384&oldid=1790314521"